spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Eitan Group Rebrands as Eitan Medical

Eitan Medical




NETANYA, Israel, November 16, 2020 – Eitan Medical announced today that, as of November 16, 2020, it has rebranded, consolidating its product lines under the new Eitan Medical brand. Eitan Medical is a global leader in advanced infusion therapy solutions across the care continuum.

Eitan Medical’s product lines include the Sapphire infusion family, used across the care continuum; Sorrel’s wearable drug delivery platform, the patient-centric on-body injector for delivery of biologic treatments; and Avoset, designed specifically for home care with dedicated connected infusion systems.

“Rebranding as Eitan Medical marks a major milestone and a unique opportunity for our new name to become synonymous with our advanced, connected infusion therapy solutions,” said Igal Shany, CEO of Eitan Medical. “Our new brand represents our evolving position – committed to delivering infusion solutions that go beyond, providing maximum flexibility for patients and reliability for clinicians across the care continuum, from the hospital to the home.”

Eitan Medical maintains local offices in the United States, France and the UK, whereby existing customers of the Sapphire product line can receive direct support and supply of infusion pumps and accessories. In addition, Eitan Medical continues to expand and successfully partner with leading pharmaceutical companies for its Sorrel wearable drug delivery platform.
email support@eitanmedical.com
web https://eitanmedical.com/
email 29 Yad Haruzim St., P.O. Box 8639, Netanya 4250529, Israel
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Sysmex Launches New Products for the Haemostasis Field in the EMEA Region: Automated Blood Coagulation Analysers CN-3500 and CN-6500 Using Chemiluminescence Enzyme Immunoassay (CLEIA) Technology to Enhance the Testing Workflow

Norderstedt, Germany, 13 July 2021 – Sysmex Europe GmbH announces the launch of new products for the haemostasis field in specific designated countries of the EMEA region: the automated blood coagulation analysers CN-3500 and CN-6500, targeted at medium- and large-scale hospitals and commercial labs, as well as other facilities.
More info >>


White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement